Home Biotechnology Industry News Genomind Presents Open Label Study Protocol Designed to Assess the…

Genomind Presents Open Label Study Protocol Designed to Assess the…

Study to Evaluate Impact of the Genecept™ Assay on Patients Outcomes Incorporates New Web-based Data Collection Approach

(PRWeb May 07, 2012)

Read the full story at http://www.prweb.com/releases/2012/5/prweb9477854.htm